Trial intelligence / Profile preview

Adjuvant chemotherapy plus radiation versus chemotherapy alone in stage III-IVA endometrial cancer

TCTR20240725003Phase 2Not yet recruiting

Sponsor
Mahidol University
Start
Aug 2024
Countries
1
01

Overview

Phase 2, randomised trial in endometrial cancer (EC) (2 arms), sponsored by Mahidol University. Planned start Aug 2024; status: not yet recruiting.

02

Conditions

endometrial cancer (EC)

Beyond the preview

Go deeper on TCTR20240725003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20240725003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call